IgG and IgM antibodies of SARS-CoV-2 detection in less than 10 minutes
The new rapid IgM-IgG combined antibody test for COVID-19 is used to qualitatively detect IgG and IgM antibodies of the novel coronavirus in human serum, plasma or whole blood in vitro. These proteins indicate that a person’s immune system has responded to infection with the COVID-19 virus.
Recent studies suggest that a high percentage of patients show no clinical symptoms of the virus, which makes screening patients vitally important. The test can be used for rapid screening of carriers of the virus that are symptomatic or asymptomatic.
By using biomarkers from the body’s immune response to SARS-CoV-2 virus instead of looking for the virus itself, the test can help determine if a person has been infected with SARS-CoV-2 virus even after the virus is no longer present.
This information helps experts to better understand how the virus spreads through populations and develop strategies to prevent and slow the epidemic. The test is for professional use only.
The Healgen new rapid IgM-IgG combined antibody test for COVID-19 has been used widely by the Chinese CDC to combat infections and is now available in the Benelux. Healgen has also received CE Mark-IVD certification for the test and the time to result is 2–10 minutes.